Kobat et al. have established lower vaspin levels in subjects with CAD as compared to controls, and this tendency has been confirmed in a control group with higher systolic blood pressure in comparison to controls with normal blood pressure. This evidence concerns the gene SERPINA12 and coronary artery disorder.